Phase 3 Screening Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 3
Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.
Prostate Cancer Screening
University of Alberta1,284 enrolled6 locationsNCT06626022
Completed
Phase 3
The influence of initial screening test technology on participation in rescreening for colorectal cancer
Screening for bowel cancer
Prof. Graeme Young MD, FRACP1,818 enrolled1 locationACTRN12605000462684
Completed
Phase 3
The value of GP endorsement on participation in rescreening for colorectal cancer
Screening for bowel cancer
Prof. Graeme Young MD, FRACP2,400 enrolled1 locationACTRN12605000461695
Active
Phase 3
Interventions to improve participation in bowel cancer screening: the value of lay advocacy and positive framing of risk.
Screening for bowel cancer
Prof. Graeme Young MD, FRACP1,800 enrolled1 locationACTRN12605000279628
Active
Phase 3
The value of an advance notification letter prior to a postal offer of bowel cancer screening on population participation in screening.
Screening for bowel cancer
Prof. Graeme Young MD, FRACP1,200 enrolled1 locationACTRN12605000239662